SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-014829
Filing Date
2024-04-16
Accepted
2024-04-16 16:30:36
Documents
14
Period of Report
2024-04-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 33487
  Complete submission text file 0001493152-24-014829.txt   207969

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nrxs-20240410.xsd EX-101.SCH 3015
3 XBRL LABEL FILE nrxs-20240410_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE nrxs-20240410_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3762
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

IRS No.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41775 | Film No.: 24848188
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 03 Life Sciences)